Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Didier Raoult and Philippe Gautret.
Didier Raoult
Connection Strength
30.510
Philippe Gautret
  1. Does SARS-CoV-2 re-infection depend on virus variant? Clin Microbiol Infect. 2021 09; 27(9):1374-1375.
    View in: PubMed
    Score: 0.953
  2. Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann. Int J Antimicrob Agents. 2021 Mar; 57(3):106306.
    View in: PubMed
    Score: 0.929
  3. Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. Int J Antimicrob Agents. 2021 Jan; 57(1):106236.
    View in: PubMed
    Score: 0.922
  4. Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. Int J Antimicrob Agents. 2021 01; 57(1):106237.
    View in: PubMed
    Score: 0.922
  5. Response to advances statistical methods and designs for clinical trials for COVID-19. Int J Antimicrob Agents. 2021 01; 57(1):106235.
    View in: PubMed
    Score: 0.922
  6. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. Int J Antimicrob Agents. 2021 Jan; 57(1):106239.
    View in: PubMed
    Score: 0.922
  7. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. Int J Antimicrob Agents. 2021 Jan; 57(1):106243.
    View in: PubMed
    Score: 0.922
  8. Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. Int J Antimicrob Agents. 2021 01; 57(1):106244.
    View in: PubMed
    Score: 0.922
  9. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. Int J Antimicrob Agents. 2021 01; 57(1):106241.
    View in: PubMed
    Score: 0.922
  10. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106242.
    View in: PubMed
    Score: 0.922
  11. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184.
    View in: PubMed
    Score: 0.920
  12. Different pattern of the second outbreak of COVID-19 in Marseille, France. Int J Infect Dis. 2021 Jan; 102:17-19.
    View in: PubMed
    Score: 0.907
  13. Nullane salus extra ecclesiam. New Microbes New Infect. 2020 Sep; 37:100714.
    View in: PubMed
    Score: 0.895
  14. Does spitting in public play a role in transmitting SARS-CoV-2? Travel Med Infect Dis. 2020 Jul - Aug; 36:101759.
    View in: PubMed
    Score: 0.885
  15. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.876
  16. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.873
  17. Global Warming and Global Decrease in Vector-Borne Disease Prevalence and Mortality. J Infect Dis. 2017 02 15; 215(4):660-661.
    View in: PubMed
    Score: 0.704
  18. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2021 Jan; 102:233-238.
    View in: PubMed
    Score: 0.455
  19. Vaccination against the big three killers: an illusion? Clin Microbiol Infect. 2019 Jun; 25(6):654-655.
    View in: PubMed
    Score: 0.407
  20. Limitations of diagnostic tests for bacterial infections. Med Mal Infect. 2019 Mar; 49(2):98-101.
    View in: PubMed
    Score: 0.403
  21. Yellow fever: the Pacific should be prepared. Lancet. 2018 12 01; 392(10162):2347.
    View in: PubMed
    Score: 0.399
  22. A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants. J Clin Med. 2021 Jul 24; 10(15).
    View in: PubMed
    Score: 0.240
  23. Evaluation of Strategies to Fight COVID-19: The French Paradigm. J Clin Med. 2021 Jun 30; 10(13).
    View in: PubMed
    Score: 0.238
  24. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. J Clin Med. 2021 Jun 15; 10(12).
    View in: PubMed
    Score: 0.238
  25. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France. Clin Microbiol Infect. 2021 Oct; 27(10):1516.e1-1516.e6.
    View in: PubMed
    Score: 0.237
  26. Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant. Int J Infect Dis. 2021 May; 106:228-236.
    View in: PubMed
    Score: 0.234
  27. COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537.
    View in: PubMed
    Score: 0.234
  28. Variations in respiratory pathogen carriage among a homeless population in a shelter for men in Marseille, France, March-July 2020: cross-sectional 1-day surveys. Eur J Clin Microbiol Infect Dis. 2021 Jul; 40(7):1579-1582.
    View in: PubMed
    Score: 0.232
  29. Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020. Int J Infect Dis. 2021 Apr; 105:1-6.
    View in: PubMed
    Score: 0.232
  30. Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study. Travel Med Infect Dis. 2021 Mar-Apr; 40:101980.
    View in: PubMed
    Score: 0.232
  31. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. 2021 Jun; 27(6):931-932.
    View in: PubMed
    Score: 0.231
  32. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis. Int J Antimicrob Agents. 2021 Jan; 57(1):106240.
    View in: PubMed
    Score: 0.230
  33. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106238.
    View in: PubMed
    Score: 0.230
  34. Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Med Infect Dis. 2021 Jan-Feb; 39:101954.
    View in: PubMed
    Score: 0.230
  35. Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020. Int J Antimicrob Agents. 2020 Dec; 56(6):106219.
    View in: PubMed
    Score: 0.228
  36. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
    View in: PubMed
    Score: 0.225
  37. Epidemiology of human common coronavirus acquisition in pilgrims. Travel Med Infect Dis. 2020 Sep - Oct; 37:101845.
    View in: PubMed
    Score: 0.224
  38. Establishing Medical Coverage and Epidemiological Surveillance during the Grand Magal of Touba in Senegal: A Public Health Need. J Epidemiol Glob Health. 2020 12; 10(4):247-249.
    View in: PubMed
    Score: 0.222
  39. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect. 2020 Nov; 38:100709.
    View in: PubMed
    Score: 0.221
  40. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.220
  41. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020 Jun; 39(6):1059-1061.
    View in: PubMed
    Score: 0.220
  42. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
    View in: PubMed
    Score: 0.218
  43. Respiratory tract infections among French Hajj pilgrims from 2014 to 2017. Sci Rep. 2019 11 28; 9(1):17771.
    View in: PubMed
    Score: 0.214
  44. Environmental investigation of respiratory pathogens during the Hajj 2016 and 2018. Travel Med Infect Dis. 2020 Jan - Feb; 33:101500.
    View in: PubMed
    Score: 0.211
  45. Rickettsia slovaca and R. raoultii in tick-borne Rickettsioses. Emerg Infect Dis. 2009 Jul; 15(7):1105-8.
    View in: PubMed
    Score: 0.208
  46. Antibiotic use for respiratory infections among Hajj pilgrims: A cohort survey and review of the literature. Travel Med Infect Dis. 2019 Jul - Aug; 30:39-45.
    View in: PubMed
    Score: 0.207
  47. Low prevalence of resistance genes in sheltered homeless population in Marseille, France, 2014-2018. Infect Drug Resist. 2019; 12:1139-1151.
    View in: PubMed
    Score: 0.205
  48. Respiratory and gastrointestinal infections at the 2017 Grand Magal de Touba, Senegal: A prospective cohort survey. Travel Med Infect Dis. 2019 May 03; 101410.
    View in: PubMed
    Score: 0.205
  49. Acquisition of respiratory viruses and presence of respiratory symptoms in French pilgrims during the 2016 Hajj: A prospective cohort study. Travel Med Infect Dis. 2019 Jul - Aug; 30:32-38.
    View in: PubMed
    Score: 0.203
  50. Antibiotic resistance, stewardship, and consumption. Lancet Planet Health. 2019 02; 3(2):e67.
    View in: PubMed
    Score: 0.202
  51. The dynamics and interactions of respiratory pathogen carriage among French pilgrims during the 2018 Hajj. Emerg Microbes Infect. 2019; 8(1):1701-1710.
    View in: PubMed
    Score: 0.201
  52. Measles: is a new vaccine approach needed? Lancet Infect Dis. 2018 10; 18(10):1060-1061.
    View in: PubMed
    Score: 0.197
  53. Towards the risk of yellow fever transmission in Europe. Clin Microbiol Infect. 2019 Jan; 25(1):10-12.
    View in: PubMed
    Score: 0.196
  54. Benefits of antibiotics burden in low-income countries. Proc Natl Acad Sci U S A. 2018 08 28; 115(35):E8109-E8110.
    View in: PubMed
    Score: 0.195
  55. Acquisition of enteric pathogens by pilgrims during the 2016 Hajj pilgrimage: A prospective cohort study. Travel Med Infect Dis. 2018 Sep - Oct; 25:26-30.
    View in: PubMed
    Score: 0.193
  56. Epidemiology of respiratory pathogen carriage in the homeless population within two shelters in Marseille, France, 2015-2017: cross sectional 1-day surveys. Clin Microbiol Infect. 2019 Feb; 25(2):249.e1-249.e6.
    View in: PubMed
    Score: 0.192
  57. Seek and Find! PCR analyses of skin infections in West-European travelers returning from abroad with an eschar. Travel Med Infect Dis. 2018 Nov - Dec; 26:32-36.
    View in: PubMed
    Score: 0.189
  58. Acute Q Fever Case Detection among Acute Febrile Illness Patients, Thailand, 2002-2005. Am J Trop Med Hyg. 2018 01; 98(1):252-257.
    View in: PubMed
    Score: 0.187
  59. Changing Demographics and Prevalence of Body Lice among Homeless Persons, Marseille, France. Emerg Infect Dis. 2017 11; 23(11):1894-1897.
    View in: PubMed
    Score: 0.185
  60. Risk factors for acquisition of CTX-M genes in pilgrims during Hajj 2013 and 2014. J Antimicrob Chemother. 2017 09 01; 72(9):2627-2635.
    View in: PubMed
    Score: 0.183
  61. Communicable and non-communicable disease risks at the Grand Magal of Touba: The largest mass gathering in Senegal. Travel Med Infect Dis. 2017 Sep; 19:56-60.
    View in: PubMed
    Score: 0.183
  62. Gut Bacteria Missing in Severe Acute Malnutrition, Can We Identify Potential Probiotics by Culturomics? Front Microbiol. 2017; 8:899.
    View in: PubMed
    Score: 0.179
  63. First molecular detection of Rickettsia felis in fleas from Algeria. Am J Trop Med Hyg. 2006 Apr; 74(4):532-5.
    View in: PubMed
    Score: 0.166
  64. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014 Nov; 20(11):1821-7.
    View in: PubMed
    Score: 0.150
  65. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014 Apr; 20(4):728-30.
    View in: PubMed
    Score: 0.144
  66. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732.
    View in: PubMed
    Score: 0.119
  67. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5).
    View in: PubMed
    Score: 0.118
  68. Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies. Eur J Clin Microbiol Infect Dis. 2021 Jun; 40(6):1309-1317.
    View in: PubMed
    Score: 0.117
  69. Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis. 2020 Sep - Oct; 37:101875.
    View in: PubMed
    Score: 0.113
  70. Cellulitis of the face associated with SENLAT caused by Rickettsia slovaca detected by qPCR on scalp eschar swab sample: An unusual case report and review of literature. Ticks Tick Borne Dis. 2019 08; 10(5):1142-1145.
    View in: PubMed
    Score: 0.103
  71. Molecular evidence of bacteria in Melophagus ovinus sheep keds and Hippobosca equina forest flies collected from sheep and horses in northeastern Algeria. Comp Immunol Microbiol Infect Dis. 2019 Aug; 65:103-109.
    View in: PubMed
    Score: 0.103
  72. Prospective case-control analysis of the aetiologies of acute undifferentiated fever in Vietnam. Emerg Microbes Infect. 2019; 8(1):339-352.
    View in: PubMed
    Score: 0.100
  73. Review of European and American guidelines for the diagnosis of Lyme borreliosis. Med Mal Infect. 2019 Mar; 49(2):121-132.
    View in: PubMed
    Score: 0.100
  74. Prevalence of antibodies to Rickettsia conorii Ricketsia africae, Rickettsia typhi and Coxiella burnetii in Mauritania. Eur J Epidemiol. 1998 Dec; 14(8):817-8.
    View in: PubMed
    Score: 0.100
  75. Tick- and flea-borne rickettsioses in Tizi-Ouzou, Algeria: Implications for travel medicine. Travel Med Infect Dis. 2018 Nov - Dec; 26:51-57.
    View in: PubMed
    Score: 0.099
  76. Longitudinal monitoring of environmental factors at Culicidae larval habitats in urban areas and their association with various mosquito species using an innovative strategy. Pest Manag Sci. 2019 Apr; 75(4):923-934.
    View in: PubMed
    Score: 0.099
  77. Insects and the Transmission of Bacterial Agents. Microbiol Spectr. 2018 10; 6(5).
    View in: PubMed
    Score: 0.099
  78. Tick-borne pathogens in removed ticks Veneto, northeastern Italy: A cross-sectional investigation. Travel Med Infect Dis. 2018 Nov - Dec; 26:58-61.
    View in: PubMed
    Score: 0.098
  79. Rickettsia massiliae infection after a tick bite on the eyelid. Travel Med Infect Dis. 2018 Nov - Dec; 26:66-68.
    View in: PubMed
    Score: 0.098
  80. Dual Genotype Orientia tsutsugamushi Infection in Patient with Rash and Eschar, Vietnam, 2016. Emerg Infect Dis. 2018 08; 24(8):1520-1523.
    View in: PubMed
    Score: 0.097
  81. Rickettsia sibirica mongolitimonae human infection: A diagnostic challenge. Travel Med Infect Dis. 2018 Nov - Dec; 26:72-73.
    View in: PubMed
    Score: 0.097
  82. Genotyping of Coxiella burnetii detected in placental tissues from aborted dairy cattle in the north of Algeria. Comp Immunol Microbiol Infect Dis. 2018 Apr; 57:50-54.
    View in: PubMed
    Score: 0.096
  83. MALDI-TOF MS identification of ticks of domestic and wild animals in Algeria and molecular detection of associated microorganisms. Comp Immunol Microbiol Infect Dis. 2018 Apr; 57:39-49.
    View in: PubMed
    Score: 0.096
  84. Body lice of homeless people reveal the presence of several emerging bacterial pathogens in northern Algeria. PLoS Negl Trop Dis. 2018 04; 12(4):e0006397.
    View in: PubMed
    Score: 0.095
  85. Detection of Bartonella spp. in fleas by MALDI-TOF MS. PLoS Negl Trop Dis. 2018 02; 12(2):e0006189.
    View in: PubMed
    Score: 0.094
  86. Using MALDI-TOF MS to identify mosquitoes collected in Mali and their blood meals. Parasitology. 2018 08; 145(9):1170-1182.
    View in: PubMed
    Score: 0.094
  87. Molecular Evidence of Rickettsia slovaca in Wild Boar Lice, in Northeastern Algeria. Vector Borne Zoonotic Dis. 2018 02; 18(2):114-116.
    View in: PubMed
    Score: 0.094
  88. Assessment of MALDI-TOF mass spectrometry for filariae detection in Aedes aegypti mosquitoes. PLoS Negl Trop Dis. 2017 12; 11(12):e0006093.
    View in: PubMed
    Score: 0.093
  89. Escherichia coli spontaneous community-acquired meningitis in adults: A case report and literature review. Int J Infect Dis. 2018 Feb; 67:70-74.
    View in: PubMed
    Score: 0.093
  90. Detection of relapsing fever Borrelia spp., Bartonella spp. and Anaplasmataceae bacteria in argasid ticks in Algeria. PLoS Negl Trop Dis. 2017 Nov; 11(11):e0006064.
    View in: PubMed
    Score: 0.093
  91. Accurate identification of Anopheles gambiae Giles trophic preferences by MALDI-TOF MS. Infect Genet Evol. 2018 09; 63:410-419.
    View in: PubMed
    Score: 0.092
  92. MALDI-TOF MS identification of Anopheles gambiae Giles blood meal crushed on Whatman filter papers. PLoS One. 2017; 12(8):e0183238.
    View in: PubMed
    Score: 0.091
  93. From Expert Protocols to Standardized Management of Infectious Diseases. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S12-S19.
    View in: PubMed
    Score: 0.091
  94. Medical Entomology: A Reemerging Field of Research to Better Understand Vector-Borne Infectious Diseases. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S30-S38.
    View in: PubMed
    Score: 0.091
  95. Field application of MALDI-TOF MS on mosquito larvae identification. Parasitology. 2018 04; 145(5):677-687.
    View in: PubMed
    Score: 0.091
  96. Molecular and MALDI-TOF identification of ticks and tick-associated bacteria in Mali. PLoS Negl Trop Dis. 2017 Jul; 11(7):e0005762.
    View in: PubMed
    Score: 0.091
  97. Comparative analysis of storage conditions and homogenization methods for tick and flea species for identification by MALDI-TOF MS. Med Vet Entomol. 2017 12; 31(4):438-448.
    View in: PubMed
    Score: 0.091
  98. Treating influenza with antibiotics. Int J Antimicrob Agents. 2017 Oct; 50(4):505-506.
    View in: PubMed
    Score: 0.090
  99. Use of eschar swabbing for the molecular diagnosis and genotyping of Orientia tsutsugamushi causing scrub typhus in Quang Nam province, Vietnam. PLoS Negl Trop Dis. 2017 02; 11(2):e0005397.
    View in: PubMed
    Score: 0.088
  100. Detection of a Potential New Bartonella Species "Candidatus Bartonella rondoniensis" in Human Biting Kissing Bugs (Reduviidae; Triatominae). PLoS Negl Trop Dis. 2017 01; 11(1):e0005297.
    View in: PubMed
    Score: 0.088
  101. Molecular survey of Dirofilaria immitis and Dirofilaria repens by new real-time TaqMan® PCR assay in dogs and mosquitoes (Diptera: Culicidae) in Corsica (France). Vet Parasitol. 2017 Feb 15; 235:1-7.
    View in: PubMed
    Score: 0.087
  102. Molecular evidence of tick-borne hemoprotozoan-parasites (Theileria ovis and Babesia ovis) and bacteria in ticks and blood from small ruminants in Northern Algeria. Comp Immunol Microbiol Infect Dis. 2017 Feb; 50:34-39.
    View in: PubMed
    Score: 0.087
  103. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Microb Drug Resist. 2021 Mar; 27(3):281-290.
    View in: PubMed
    Score: 0.058
  104. Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2021 Feb 16; 12(1):21.
    View in: PubMed
    Score: 0.058
  105. Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time. J Med Virol. 2021 04; 93(4):1878-1881.
    View in: PubMed
    Score: 0.057
  106. Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2020 Nov 17; 11(1):117.
    View in: PubMed
    Score: 0.057
  107. Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371.
    View in: PubMed
    Score: 0.057
  108. Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score. PLoS One. 2020; 15(11):e0241407.
    View in: PubMed
    Score: 0.057
  109. Clusters of COVID-19 associated with Purim celebration in the Jewish community in Marseille, France, March 2020. Int J Infect Dis. 2020 Nov; 100:88-94.
    View in: PubMed
    Score: 0.056
  110. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
    View in: PubMed
    Score: 0.056
  111. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
    View in: PubMed
    Score: 0.054
  112. Spotted fever group rickettsiae in ticks, Morocco. Emerg Infect Dis. 2008 Jul; 14(7):1067-73.
    View in: PubMed
    Score: 0.048
  113. Endocarditis in the Mediterranean Basin. New Microbes New Infect. 2018 Nov; 26:S43-S51.
    View in: PubMed
    Score: 0.048
  114. MALDI-TOF MS protein profiling for the rapid identification of Chagas disease triatomine vectors and application to the triatomine fauna of French Guiana - CORRIGENDUM. Parasitology. 2018 04; 145(5):676.
    View in: PubMed
    Score: 0.046
  115. MALDI-TOF MS protein profiling for the rapid identification of Chagas disease triatomine vectors and application to the triatomine fauna of French Guiana. Parasitology. 2018 04; 145(5):665-675.
    View in: PubMed
    Score: 0.045
  116. Detection of Rickettsia helvetica in Ixodes ricinus ticks collected from Pyrenean chamois in France. Ticks Tick Borne Dis. 2012 Dec; 3(5-6):387-8.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.